120 related articles for article (PubMed ID: 3111892)
1. In vitro fertilization and embryo transfer in patients with one ovary.
Dodds WG; Chin N; Awadalla SG; Miller F; Friedman C; Kim M
Fertil Steril; 1987 Aug; 48(2):249-53. PubMed ID: 3111892
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcome in women with a single ovary versus patients with two ovaries undergoing in vitro fertilization and embryo transfer (IVF/ET).
Levitas E; Furman B; Shoham-Vardi I; Lunenfeld E; Potashnik G
Eur J Obstet Gynecol Reprod Biol; 2000 Feb; 88(2):197-200. PubMed ID: 10690680
[TBL] [Abstract][Full Text] [Related]
3. Comparison of follicular response in patients with one or two ovaries in a program of in vitro fertilization.
Alper MM; Seibel MM; Oskowitz SP; Smith BD; Ransil BJ; Taymor ML
Fertil Steril; 1985 Nov; 44(5):652-5. PubMed ID: 3932102
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of exogenous gonadotropin and ovarian response in in vitro fertilization.
Nagata Y; Honjou K; Sonoda M; Sumii Y; Inoue Y; Kawarabayashi T
Fertil Steril; 1999 Aug; 72(2):235-9. PubMed ID: 10438987
[TBL] [Abstract][Full Text] [Related]
5. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
[TBL] [Abstract][Full Text] [Related]
6. The appearance of one-pronuclear human oocytes is associated with a better ovulation-induction response and successful pregnancy outcome.
Jackson KV; Nureddin A; Clarke RN; Hornstein MD; Rein MS; Friedman AJ
Fertil Steril; 1992 Aug; 58(2):366-72. PubMed ID: 1633904
[TBL] [Abstract][Full Text] [Related]
7. The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: a prospective randomized study.
Tan SL; Balen A; el Hussein E; Campbell S; Jacobs HS
Fertil Steril; 1992 Aug; 58(2):378-83. PubMed ID: 1633906
[TBL] [Abstract][Full Text] [Related]
8. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro fertilization results in women with one or two ovaries.
Dodson MG; Young RL; Poindexter AN; Gibbons WE; Rossavik IK; Findley WE
J Reprod Med; 1987 May; 32(5):359-62. PubMed ID: 3598984
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized study of the optimum timing of human chorionic gonadotropin administration after pituitary desensitization in in vitro fertilization.
Tan SL; Balen A; el Hussein E; Mills C; Campbell S; Yovich J; Jacobs HS
Fertil Steril; 1992 Jun; 57(6):1259-64. PubMed ID: 1601148
[TBL] [Abstract][Full Text] [Related]
12. Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program.
Lass A; Ellenbogen A; Croucher C; Trew G; Margara R; Becattini C; Winston RM
Fertil Steril; 1998 Dec; 70(6):1035-8. PubMed ID: 9848291
[TBL] [Abstract][Full Text] [Related]
13. Dose of human menopausal gonadotropin influences the outcome of an in vitro fertilization program.
Ben-Rafael Z; Benadiva CA; Ausmanas M; Barber B; Blasco L; Flickinger GL; Mastroianni L
Fertil Steril; 1987 Dec; 48(6):964-8. PubMed ID: 3119377
[TBL] [Abstract][Full Text] [Related]
14. Effect of oocyte retrieval from a small leading follicle in fixed-schedule in vitro fertilization program.
Nagai S; Yasumizu T; Kasai T; Hirata S; Mizuno K; Kato J
J Obstet Gynaecol Res; 1997 Apr; 23(2):165-9. PubMed ID: 9158304
[TBL] [Abstract][Full Text] [Related]
15. The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility.
Dor J; Shulman A; Levran D; Ben-Rafael Z; Rudak E; Mashiach S
Hum Reprod; 1990 Oct; 5(7):816-8. PubMed ID: 2266154
[TBL] [Abstract][Full Text] [Related]
16. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
Lindheim SR; Cohen MA; Chang PL; Sauer MV
J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
[TBL] [Abstract][Full Text] [Related]
17. Serum progesterone concentrations on the day after human chorionic gonadotropin administration and progesterone/oocyte ratios predict in vitro fertilization/embryo transfer outcome.
Burns WN; Witz CA; Klein NA; Silverberg KM; Schenken RS
J Assist Reprod Genet; 1994 Jan; 11(1):17-23. PubMed ID: 7949830
[TBL] [Abstract][Full Text] [Related]
18. The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study.
Younis JS; Simon A; Koren R; Dorembus D; Schenker JG; Laufer N
Fertil Steril; 1992 Sep; 58(3):575-80. PubMed ID: 1387849
[TBL] [Abstract][Full Text] [Related]
19. Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study.
Lavy G; Pellicer A; Diamond MP; DeCherney AH
Fertil Steril; 1988 Jul; 50(1):74-8. PubMed ID: 3133250
[TBL] [Abstract][Full Text] [Related]
20. One ovary or two: differences in ovulation induction, estradiol levels, and follicular development in a program for in vitro fertilization.
Diamond MP; Wentz AC; Herbert CM; Pittaway DE; Maxson WS; Daniell JF
Fertil Steril; 1984 Apr; 41(4):524-9. PubMed ID: 6423412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
